STOCK TITAN

Exact Sciences to participate in February investor conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Exact Sciences Corp. (Nasdaq: EXAS) announced its participation in upcoming virtual conferences. Notable events include the SVB Leerink Global Healthcare Conference on February 18, 2022, at 1:40 p.m. ET, and the Citi Healthcare Conference on February 23, 2022, at 2:45 p.m. ET. Investors can join the webcasts via the investor relations section on Exact Sciences' website. Exact Sciences is dedicated to developing cancer screening and diagnostic tests, including the well-known Cologuard and Oncotype DX.

Positive
  • None.
Negative
  • None.

MADISON, Wis., Feb. 1, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following virtual conferences and invited investors to participate by webcast.

  • SVB Leerink Global Healthcare Conference
    Fireside Chat on Friday, February 18, 2022 at 1:40 p.m. ET
     
  • Citi Healthcare Conference
    Fireside Chat on Wednesday, February 23, 2022 at 2:45 p.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com 
608-535-8815

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-february-investor-conferences-301472417.html

SOURCE Exact Sciences Corporation

FAQ

What are the upcoming virtual conferences for Exact Sciences Corp. (EXAS) in February 2022?

Exact Sciences will participate in the SVB Leerink Global Healthcare Conference on February 18, 2022, and the Citi Healthcare Conference on February 23, 2022.

How can investors access the webcasts for Exact Sciences Corp. (EXAS) conferences?

Investors can access the webcasts through the investor relations section of Exact Sciences' website.

What is the focus of Exact Sciences Corp. (EXAS) in the healthcare industry?

Exact Sciences focuses on developing innovative cancer screening and diagnostic tests, notably Cologuard and Oncotype DX.

When is the SVB Leerink Global Healthcare Conference for Exact Sciences (EXAS)?

The SVB Leerink Global Healthcare Conference for Exact Sciences is scheduled for February 18, 2022, at 1:40 p.m. ET.

What time is the Citi Healthcare Conference for Exact Sciences Corp. (EXAS)?

The Citi Healthcare Conference for Exact Sciences will take place on February 23, 2022, at 2:45 p.m. ET.

Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Stock Data

10.55B
182.40M
1.01%
101.74%
7.48%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
MADISON